Back
Results - Announcements
Sales decline 0.02% to Rs 43.04 crore
Medicamen Biotech consolidated net profit rises 59.26% in the June 2025 quarter
12-Aug-2025, 05:51
Net profit of Medicamen Biotech rose 59.26% to Rs 2.15 crore in the quarter ended June 2025 as against Rs 1.35 crore during the previous quarter ended June 2024. Sales declined 0.02% to Rs 43.04 crore in the quarter ended June 2025 as against Rs 43.05 crore during the previous quarter ended June 2024.
Net profit of Medicamen Biotech rose 59.26% to Rs 2.15 crore in the quarter ended June 2025 as against Rs 1.35 crore during the previous quarter ended June 2024. Sales declined 0.02% to Rs 43.04 crore in the quarter ended June 2025 as against Rs 43.05 crore during the previous quarter ended June 2024.
Particulars | Quarter Ended | ||
Jun. 2025 | Jun. 2024 | % Var. | |
Sales | 43.04 | 43.05 | 0 |
OPM % | 10.73 | 7.99 | - |
PBDT | 3.93 | 3.33 | 18 |
PBT | 2.13 | 1.56 | 37 |
NP | 2.15 | 1.35 | 59 |
Powered by Capital Market - Live News